Gilead Sciences (GILD) Insider Makes Significant Share Sale

Wednesday, February 21, 2018 10:15 PM ET

Gilead Sciences (GILD) Insider Makes Significant Share Sale

One insider — Gregg H Alton, Officer — today, sold 14,435 shares of Gilead Sciences having a market value of approximately $1,176,992, as disclosed in a form 4 document filed with the SEC. This is the first insider buy/sell trade in the past 90 days.

This number of buy-sell trades at Gilead Sciences is near average for the 281 member peer company. The Bio Therapeutic Drugs peer group saw 317 buy/sell trades during this period for an average of 1.1 transactions per company. However, trading at Gilead Sciences represents a lower number of shares per transaction. Within the peer group there were 25,857,165 shares purchased and 16,029,831 shares sold with company insiders having bought 50,397 shares on average over this time period.

The data sourced in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at info@uptickdata.com. Copyright 2018 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.